{'52WeekChange': -0.7300236,
 'SandP52WeekChange': None,
 'address1': '16305-36th Avenue North',
 'address2': 'Suite 100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.92,
 'askSize': 900,
 'averageDailyVolume10Day': 15000,
 'averageVolume': 32539,
 'averageVolume10days': 15000,
 'beta': 0.976303,
 'beta3Year': None,
 'bid': 5.59,
 'bidSize': 800,
 'bookValue': 1.708,
 'category': None,
 'circulatingSupply': None,
 'city': 'Minneapolis',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 6.04,
 'dayLow': 5.57,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -5.224,
 'enterpriseToRevenue': None,
 'enterpriseValue': 40664616,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 7.1097145,
 'fiftyTwoWeekHigh': 23.8,
 'fiftyTwoWeekLow': 4.03,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 5370104,
 'forwardEps': -0.84,
 'forwardPE': -6.6547623,
 'fromCurrency': None,
 'fullTimeEmployees': 27,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.50778,
 'heldPercentInstitutions': 0.22049999,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/celcuity.com',
 'longBusinessSummary': 'Celcuity Inc., a cellular analysis company, discovers '
                        'cancer sub-types and commercializes diagnostic tests '
                        'to enhance the clinical outcomes of cancer patients '
                        'treated with targeted therapies in the United States. '
                        "The company's CELx diagnostic platform uses a "
                        "patient's living tumor cells to identify the specific "
                        "abnormal cellular process driving a patient's cancer "
                        'and the targeted therapy that treats it. It is '
                        'developing CELx HSF test to diagnose two new '
                        'sub-types of HER2-negative breast cancer. The company '
                        'is also developing CELx MP test to diagnose 12 new '
                        'potential cancer sub-types in breast, lung, colon, '
                        'ovarian, kidney, and bladder cancers. Celcuity Inc. '
                        'was founded in 2011 and is headquartered in '
                        'Minneapolis, Minnesota.',
 'longName': 'Celcuity Inc.',
 'market': 'us_market',
 'marketCap': 57433896,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_254573983',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -7760451,
 'nextFiscalYearEnd': 1640908800,
 'open': 6,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.53,
 'phone': '763-392-0767',
 'previousClose': 5.71,
 'priceHint': 2,
 'priceToBook': 3.2728338,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 6.04,
 'regularMarketDayLow': 5.57,
 'regularMarketOpen': 6,
 'regularMarketPreviousClose': 5.71,
 'regularMarketPrice': 6,
 'regularMarketVolume': 17621,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 10258700,
 'sharesPercentSharesOut': 0.0104,
 'sharesShort': 106353,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 89365,
 'shortName': 'Celcuity Inc.',
 'shortPercentOfFloat': 0.018,
 'shortRatio': 1.74,
 'startDate': None,
 'state': 'MN',
 'strikePrice': None,
 'symbol': 'CELC',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.758,
 'twoHundredDayAverage': 7.845,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '3823f702-835a-3171-9799-5e1fe94326a8',
 'volume': 17621,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.celcuity.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '55446'}